| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 80.30B | 88.40B | 79.28B | 83.76B | 68.79B | 58.88B |
| Gross Profit | 65.82B | 70.22B | 63.76B | 74.52B | 67.41B | 55.59B |
| EBITDA | 19.88B | 22.47B | 17.13B | 16.34B | 18.29B | 8.44B |
| Net Income | 13.98B | 13.70B | 9.64B | 9.17B | 11.70B | 2.56B |
Balance Sheet | ||||||
| Total Assets | 5.70T | 5.75T | 5.84T | 5.81T | 5.75T | 5.38T |
| Cash, Cash Equivalents and Short-Term Investments | 0.00 | 861.93B | 1.08T | 1.20T | 1.12T | 893.02B |
| Total Debt | 508.20B | 621.79B | 630.88B | 644.79B | 736.57B | 784.95B |
| Total Liabilities | 5.37T | 5.43T | 5.51T | 5.53T | 5.46T | 5.08T |
| Stockholders Equity | 336.83B | 328.26B | 329.19B | 281.10B | 284.33B | 291.70B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -715.00M | 0.00 | -154.66B | 0.00 | 213.53B |
| Operating Cash Flow | 0.00 | 1.44B | 0.00 | -152.15B | 0.00 | 216.35B |
| Investing Cash Flow | 0.00 | -162.56B | -16.58B | 227.01B | -29.11B | 27.36B |
| Financing Cash Flow | 0.00 | -67.45B | -33.92B | -3.19B | 105.75B | -2.44B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | ¥241.71B | 14.45 | ― | 2.13% | 7.77% | 5.80% | |
71 Outperform | ¥259.97B | 8.21 | 7.61% | 3.81% | 17.68% | 20.15% | |
68 Neutral | ¥262.23B | 9.68 | ― | 2.27% | 2.68% | 74.80% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
65 Neutral | ¥242.20B | 8.20 | ― | 3.46% | 11.92% | 16.40% | |
65 Neutral | ¥231.12B | 10.90 | ― | 2.53% | 7.67% | 11.03% | |
59 Neutral | ¥245.24B | 10.68 | ― | 2.55% | -0.36% | 41.38% |